Cargando…
Predicting T‐cell quality during manufacturing through an artificial intelligence‐based integrative multiomics analytical platform
Large‐scale, reproducible manufacturing of therapeutic cells with consistently high quality is vital for translation to clinically effective and widely accessible cell therapies. However, the biological and logistical complexity of manufacturing a living product, including challenges associated with...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115702/ https://www.ncbi.nlm.nih.gov/pubmed/35600660 http://dx.doi.org/10.1002/btm2.10282 |